Pneumococcal meningitis: a clinical and laboratory study. by Tugwell, P, Greenwood, B, Warrell, D

Etanercept for the treatment of rheumatoid arthritis. by Lethaby, A, Lopez-Olivo, M, Maxwell, L, Burls, A, Tugwell, P, Wells, G

Infliximab for the treatment of rheumatoid arthritis. by Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P

Developing core outcome sets for clinical trials: issues to consider. by Williamson, P, Altman, D, Blazeby, J, Clarke, M, Devane, D, Gargon, E, Tugwell, P

Etanercept for the treatment of rheumatoid arthritis. by Blumenauer, B, Judd, M, Cranney, A, Burls, A, Coyle, D, Hochberg, M, Tugwell, P, Wells, G

Etanercept for the treatment of rheumatoid arthritis by Blumenauer, B, Judd, M, Cranney, A, Burls, A, Coyle, D, Hochberg, M, Tugwell, P, Wells, G

Core outcome Set-STAndards for reporting: the COS-STAR statement by Kirkham, J, Gorst, S, Altman, D, Blazeby, J, Clarke, M, Devane, D, Gargon, E, Moher, D, Schmitt, J, Tugwell, P, Tunis, S, Williamson, P

A research and development agenda for systematic reviews that ask complex questions about complex interventions by Noyes, J, Gough, D, Lewin, S, Mayhew, A, Michie, S, Pantoja, T, Petticrew, M, Pottie, K, Rehfuess, E, Shemilt, I, Shepperd, S, Sowden, A, Tugwell, P, Welch, V

Trial of chloramphenicol for meningitis in northern savanna of Africa. by Whittle, H, Davidson, N, Greenwood, B, Warrell, D, Tomkins, A, Tugwell, P, Zalin, A, Bryceson, A, Parry, E, Brueton, M, Duggan, M, Rajković, A

A research and development agenda for systematic reviews that ask complex questions about complex interventions. by Noyes, J, Gough, D, Lewin, S, Mayhew, A, Michie, S, Pantoja, T, Petticrew, M, Pottie, K, Rehfuess, E, Shemilt, I, Shepperd, S, Sowden, A, Tugwell, P, Welch, V

Meningococcal antigen in diagnosis and treatment of group A meningococcal infections. by Whittle, H, Greenwood, B, Davidson, N, Tomkins, A, Tugwell, P, Warrell, D, Zalin, A, Bryceson, A, Parry, E, Brueton, M, Duggan, M, Oomen, J, Rajkovic, A

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: cross sectional meta-research study by Nguyen, P, Kanukula, R, McKenzie, JE, Alqaidoom, Z, Brennan, SE, Haddaway, NR, Hamilton, DG, Karunananthan, S, McDonald, S, Moher, D, Nakagawa, S, Nunan, D, Tugwell, P, Welch, VA, Page, MJ

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evide... by Zhang, W, Moskowitz, R, Nuki, G, Abramson, S, Altman, R, Arden, N, Bierma-Zeinstra, S, Brandt, K, Croft, P, Doherty, M, Dougados, M, Hochberg, M, Hunter, D, Kwoh, K, Lohmander, L, Tugwell, P

Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). by Lewin, S, Hendry, M, Chandler, J, Oxman, A, Michie, S, Shepperd, S, Reeves, B, Tugwell, P, Hannes, K, Rehfuess, E, Welch, V, Mckenzie, J, Burford, B, Petkovic, J, Anderson, L, Harris, J, Noyes, J

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. by Zhang, W, Moskowitz, R, Nuki, G, Abramson, S, Altman, R, Arden, N, Bierma-Zeinstra, S, Brandt, K, Croft, P, Doherty, M, Dougados, M, Hochberg, M, Hunter, D, Kwoh, K, Lohmander, L, Tugwell, P

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January... by Zhang, W, Nuki, G, Moskowitz, R, Abramson, S, Altman, R, Arden, N, Bierma-Zeinstra, S, Brandt, K, Croft, P, Doherty, M, Dougados, M, Hochberg, M, Hunter, D, Kwoh, K, Lohmander, L, Tugwell, P

Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. by Sinha, I, Altman, D, Beresford, M, Boers, M, Clarke, M, Craig, J, Alberighi, O, Fernandes, R, Hartling, L, Johnston, B, Lux, A, Plint, A, Tugwell, P, Turner, M, van der Lee, J, Offringa, M, Williamson, P, Smyth, R

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. by Lassere, M, Johnson, K, Boers, M, Tugwell, P, Brooks, P, Simon, L, Strand, V, Conaghan, P, Ostergaard, M, Maksymowych, W, Landewe, R, Bresnihan, B, Tak, P, Wakefield, R, Mease, P, Bingham, C, Hughes, M, Altman, D, Buyse, M, Galbraith, S, Wells, G

Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC) by Lawson, DO, Puljak, L, Pieper, D, Schandelmaier, S, Collins, GS, Brignardello-Petersen, R, Moher, D, Tugwell, P, Welch, VA, Samaan, Z, Thombs, BD, Nørskov, AK, Jakobsen, JC, Allison, DB, Mayo-Wilson, E, Young, T, Chan, A-W, Briel, M, Guyatt, GH, Thabane, L, Mbuagbaw, L

The Omeract-Oarsi core set of outcome domains to measure in clinical trials for people with hip and/or knee osteoarthritis by Smith, T, Hawker, G, Hunter, D, March, L, Shea, B, Christensen, R, Guillemin, F, Terwee, C, Williamson, P, Roos, E, Loeser, R, Schnitzer, T, Kloppenburg, M, Neogi, T, Ladel, C, Kaiser, U, Mobasheri, A, Arden, N, Hochberg, M, Tennant, A, De Wit, M, Tugwell, P, Conaghan, P